A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.84 NZD 1.43% Market Closed
Market Cap: 297.8m NZD
Have any thoughts about
AFT Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one AFT stock under the Base Case scenario is 4.72 NZD. Compared to the current market price of 2.84 NZD, AFT Pharmaceuticals Ltd is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AFT Intrinsic Value
4.72 NZD
Undervaluation 40%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
AFT Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
AFT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AFT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about AFT?
Bearish
Neutral
Bullish

Fundamental Analysis

2.84 NZD
+1.43%
+1.43%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AFT Pharmaceuticals Ltd
NZ
Pharmaceuticals
Market Cap
297.8m NZD
IPO
Dec 22, 2015
Employees
94
New Zealand
Market Cap
297.8m NZD
Industry
Pharmaceuticals
IPO
Dec 22, 2015
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about AFT Pharmaceuticals Ltd

Provide an overview of the primary business activities
of AFT Pharmaceuticals Ltd.

What unique competitive advantages
does AFT Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does AFT Pharmaceuticals Ltd face in the near future?

Summarize the latest earnings call
of AFT Pharmaceuticals Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AFT Pharmaceuticals Ltd.

Provide P/S
for AFT Pharmaceuticals Ltd.

Provide P/E
for AFT Pharmaceuticals Ltd.

Provide P/OCF
for AFT Pharmaceuticals Ltd.

Provide P/FCFE
for AFT Pharmaceuticals Ltd.

Provide P/B
for AFT Pharmaceuticals Ltd.

Provide EV/S
for AFT Pharmaceuticals Ltd.

Provide EV/GP
for AFT Pharmaceuticals Ltd.

Provide EV/EBITDA
for AFT Pharmaceuticals Ltd.

Provide EV/EBIT
for AFT Pharmaceuticals Ltd.

Provide EV/OCF
for AFT Pharmaceuticals Ltd.

Provide EV/FCFF
for AFT Pharmaceuticals Ltd.

Provide EV/IC
for AFT Pharmaceuticals Ltd.

Show me price targets
for AFT Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for AFT Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for AFT Pharmaceuticals Ltd?

What are the Net Income projections
for AFT Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for AFT Pharmaceuticals Ltd?

What are the EPS projections
for AFT Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for AFT Pharmaceuticals Ltd?

What are the EBIT projections
for AFT Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for AFT Pharmaceuticals Ltd?

Compare the revenue forecasts
for AFT Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AFT Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AFT Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of AFT Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of AFT Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing AFT Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of AFT Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for AFT Pharmaceuticals Ltd.

Provide ROE
for AFT Pharmaceuticals Ltd.

Provide ROA
for AFT Pharmaceuticals Ltd.

Provide ROIC
for AFT Pharmaceuticals Ltd.

Provide ROCE
for AFT Pharmaceuticals Ltd.

Provide Gross Margin
for AFT Pharmaceuticals Ltd.

Provide Operating Margin
for AFT Pharmaceuticals Ltd.

Provide Net Margin
for AFT Pharmaceuticals Ltd.

Provide FCF Margin
for AFT Pharmaceuticals Ltd.

Show all solvency ratios
for AFT Pharmaceuticals Ltd.

Provide D/E Ratio
for AFT Pharmaceuticals Ltd.

Provide D/A Ratio
for AFT Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for AFT Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for AFT Pharmaceuticals Ltd.

Provide Quick Ratio
for AFT Pharmaceuticals Ltd.

Provide Current Ratio
for AFT Pharmaceuticals Ltd.

Provide Cash Ratio
for AFT Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for AFT Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for AFT Pharmaceuticals Ltd?

What is the current Free Cash Flow
of AFT Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for AFT Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AFT Pharmaceuticals Ltd

Current Assets 86.8m
Cash & Short-Term Investments 10.7m
Receivables 28m
Other Current Assets 48.1m
Non-Current Assets 61.1m
PP&E 3.5m
Intangibles 56.5m
Other Non-Current Assets 1.1m
Current Liabilities 31.9m
Accounts Payable 25.3m
Other Current Liabilities 6.6m
Non-Current Liabilities 32.2m
Long-Term Debt 32.4m
Other Non-Current Liabilities -270k
Efficiency

Earnings Waterfall
AFT Pharmaceuticals Ltd

Revenue
198.5m NZD
Cost of Revenue
-110m NZD
Gross Profit
88.5m NZD
Operating Expenses
-69.4m NZD
Operating Income
19.2m NZD
Other Expenses
-7.6m NZD
Net Income
11.6m NZD

Free Cash Flow Analysis
AFT Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AFT Profitability Score
Profitability Due Diligence

AFT Pharmaceuticals Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
Positive 3-Year Average ROIC
58/100
Profitability
Score

AFT Pharmaceuticals Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

AFT Solvency Score
Solvency Due Diligence

AFT Pharmaceuticals Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
68/100
Solvency
Score

AFT Pharmaceuticals Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 3.8 NZD with a low forecast of 3.03 NZD and a high forecast of 4.67 NZD.

Lowest
Price Target
3.03 NZD
7% Upside
Average
Price Target
3.8 NZD
34% Upside
Highest
Price Target
4.67 NZD
65% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AFT?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AFT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one AFT stock?

The intrinsic value of one AFT stock under the Base Case scenario is 4.72 NZD.

Is AFT stock undervalued or overvalued?

Compared to the current market price of 2.84 NZD, AFT Pharmaceuticals Ltd is Undervalued by 40%.

Back to Top